Results 191 to 200 of about 10,822,632 (330)

HIV Controllers Maintain a Population of Highly Efficient Th1 Effector Cells in Contrast to Patients Treated in the Long Term [PDF]

, 2012
Benoît Vingert, Daniela Benati, Olivier Lambotte, Pierre de Truchis, Laurence Slama, Patricia Jeannin, Moran Galperin, Santiago Pérez-Patrigeón, Faroudy Boufassa, William W. Kwok, Fabrice Lemaı̂tre, Jean‐François Delfraissy, Jacques Thèze, Lisa A. Chakrabarti   +13 more
openalex   +1 more source

A Prussian Blue Nanozyme‐Adjuvanted Vaccine Presenting Phosphocholine Antigens for Induction of Immunotolerance in Inflammatory Bowel Disease

Advanced Science, EarlyView.
ABSTRACT Inflammatory bowel disease (IBD) is a complex disorder characterized by chronic intestinal inflammation and impaired barrier function, for which effective long‐term therapies remain elusive. To address this challenge, we developed a novel nano‐vaccine that combines Prussian blue nanozymes (PBNZs) adjuvants with a ferritin carrier loaded with ...
Jingyi Sheng, Yubo Huang, Xinyue Li, Yin Liu, Yuehuang Wu, Yuxin Zhang, Ning Gu   +6 more
wiley   +1 more source

The FoxO4/DKK3 axis represses IFN-γ expression by Th1 cells and limits antimicrobial immunity. [PDF]

J Clin Invest
Chen X, Hu J, Wang Y, Lee Y, Zhao X, Lu H, Zhu G, Wang H, Jiang Y, Liu F, Chen Y, Kim BS, Zhou Q, Liu X, Wang X, Chang SH, Dong C.   +16 more
europepmc   +1 more source

Th1 cells are dispensable for primary clearance of Chlamydia from the female reproductive tract of mice. [PDF]

PLoS Pathog, 2022
Rixon JA, Depew CE, McSorley SJ.
europepmc   +1 more source

Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation [PDF]

, 2018
Difeng Fang, Kairong Cui, Gangqing Hu, Rama Krishna Gurram, Chao Zhong, Andrew J. Oler, Ryoji Yagi, Ming Zhao, Suveena Sharma, Pentao Liu, Bing Sun, Keji Zhao, Jinfang Zhu   +12 more
openalex   +1 more source

ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells.

Blood, 2014
S. Guedan, Xi Chen, Aviv Madar, C. Carpenito, S. McGettigan, M. Frigault, Jihyun Lee, A. Posey, J. Scholler, N. Scholler, Richard Bonneau, C. June   +11 more
semanticscholar   +1 more source

CXC Chemokine‐Driven Vascular Reprogramming: Modulating Tumor Vasculature to Boost Therapeutic Response

Advanced Science, EarlyView.
Tumor vascular remodeling is discussed from a chemokine‐centered perspective. This review summarizes the bidirectional, temporal, and tissue‐specific roles of CXC chemokines in regulating vascular function and immune accessibility. A functional vascular normalization score is introduced as a conceptual framework to integrate dynamic vascular and immune
Hongdan Chen, Yinde Huang, Juntong Wu, Ziying Yi, Yao Li, Zeyu Yang, Fan Zhang, Chong Li   +7 more
wiley   +1 more source

IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease. [PDF]

J Clin Invest, 2022
Dwyer GK, Mathews LR, Villegas JA, Lucas A, Gonzalez de Peredo A, Blazar BR, Girard JP, Poholek AC, Luther SA, Shlomchik W, Turnquist HR.   +10 more
europepmc   +1 more source

Nrf2 activation by sulforaphane restores the age-related decrease of TH1 immunity: Role of dendritic cells [PDF]

, 2008
Hyon‐Jeen Kim, Berenice Barajas, Meiying Wang, André E. Nel   +3 more
openalex   +1 more source

Toward a Rational Design of Conjugated Copolymers with Oxygenated Side Chains for Boosting Thermoelectric Properties

Advanced Energy Materials, EarlyView.
The molecular design strategy that integrates both side chain and backbone engineering in diketopyrrolopyrrole‐based conjugated polymers to identify the optimal balance between doping efficiency and microstructural order is demonstrated. Comprehensive spectroscopic, electrochemical, morphological, and structural characterizations reveal that the ...
Taewoong Han, Suhui Sim, Hoimin Kim, Taewoong Yoon, Hyungju Ahn, Seungjoo Chang, Namgyu Park, Hajeong Kim, Shabaz Alam, Dongki Lee, Sungjun Park, Sungjoo Lee, Jaewon Lee, Boseok Kang   +13 more
wiley   +1 more source